Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC.ALNY · Entity 3132 | Director · Chief Executive Officer | September 19, 2026 | September 22, 2026 |
| Moelis & CoMC · Entity 3898 | Director | November 14, 2018 | November 16, 2018 |
| Pacira BioSciences, Inc.PCRX · Entity 4928 | Director | June 08, 2022 | June 08, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ALNYLAM PHARMACEUTICALS, INC.
Report date September 19, 2026 · Filed September 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 95,802 |
Reported balance
After 2026-09-19 transaction · row 1
1 source rowRow 1 · 2026-09-19 · Grant · Acquired 107 · Balance 95,802 F1: On February 23, 2016, the People, Culture, and Compensation Committee of the issuer approved the issuance of shares of Company common stock having an aggregate value of USD $50,000 to each employee who completes 10 consecutive years of employment. The shares issued and reported here on Form 4, net of the minimum statutory tax liability, were issued to the reporting person in recognition of 10 years of continuous employment on September 19, 2026. |
| Common StockSEC Table I · non-derivative | Indirectby Managed Account | 407 |
Reported balance
Holding disclosure · report date 2026-09-19 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 407 F2: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. |
Filing footnotes · ownership attribution and instrument terms
F1: On February 23, 2016, the People, Culture, and Compensation Committee of the issuer approved the issuance of shares of Company common stock having an aggregate value of USD $50,000 to each employee who completes 10 consecutive years of employment. The shares issued and reported here on Form 4, net of the minimum statutory tax liability, were issued to the reporting person in recognition of 10 years of continuous employment on September 19, 2026.
F2: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
Moelis & Co
Report date November 14, 2018 · Filed November 16, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| 2017 Annual Restricted Stock UnitsSEC Table I · non-derivative | Direct | 1,156.96 |
Reported balance
After 2018-11-14 transaction · row 1
1 source rowRow 1 · 2018-11-14 · Grant · Acquired 13.39 · Balance 1,156.96 F1: Each Initial Restricted Stock Unit (RSU) represents the right to receive one share of Class A common stock. F2: 2017 Annual RSUs were issued as dividend equivalents on holder's underlying Annual RSUs issued on July 1, 2017. The dividend equivalent Annual RSUs will vest concurrently with the vesting of the underlying Annual RSUs. |
| 2018 Annual Restricted Stock UnitsSEC Table I · non-derivative | Direct | 706.23 |
Reported balance
After 2018-11-14 transaction · row 2
1 source rowRow 2 · 2018-11-14 · Grant · Acquired 8.17 · Balance 706.23 F1: Each Initial Restricted Stock Unit (RSU) represents the right to receive one share of Class A common stock. F3: 2018 Annual RSUs were issued as dividend equivalents on holder's underlying Annual RSUs issued on July 2, 2018. The dividend equivalent Annual RSUs will vest concurrently with the vesting of the underlying Annual RSUs. |
| 2018 Elective Restricted Stock UnitsSEC Table I · non-derivative | Direct | 1,059.34 |
Reported balance
After 2018-11-14 transaction · row 3
1 source rowRow 3 · 2018-11-14 · Grant · Acquired 12.26 · Balance 1,059.34 F1: Each Initial Restricted Stock Unit (RSU) represents the right to receive one share of Class A common stock. F4: 2018 Elective RSUs were issued as dividend equivalents on holder's underlying Elective RSUs issued on July 2, 2018. The dividend equivalent Elective RSUs will vest concurrently with the vesting of the underlying Elective RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Initial Restricted Stock Unit (RSU) represents the right to receive one share of Class A common stock.
F2: 2017 Annual RSUs were issued as dividend equivalents on holder's underlying Annual RSUs issued on July 1, 2017. The dividend equivalent Annual RSUs will vest concurrently with the vesting of the underlying Annual RSUs.
F3: 2018 Annual RSUs were issued as dividend equivalents on holder's underlying Annual RSUs issued on July 2, 2018. The dividend equivalent Annual RSUs will vest concurrently with the vesting of the underlying Annual RSUs.
F4: 2018 Elective RSUs were issued as dividend equivalents on holder's underlying Elective RSUs issued on July 2, 2018. The dividend equivalent Elective RSUs will vest concurrently with the vesting of the underlying Elective RSUs.
Pacira BioSciences, Inc.
Report date June 08, 2022 · Filed June 08, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,247 |
Reported balance
After 2022-06-08 transaction · row 1
1 source rowRow 1 · 2022-06-08 · Grant · Acquired 1,160 · Balance 13,247 F1: Represents restricted stock units that vest on June 3, 2023, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $59.39 · Expires 2032-06-08 | Direct | 8,225 |
Reported balance
After 2022-06-08 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-06-08 · Grant · Acquired 8,225 · Balance 8,225 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units that vest on June 3, 2023, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 17, 2018 Filed May 21, 2018 16:31 UTC | Moelis & Co MC · Entity 3898 | Grant2017 Annual Restricted Stock Units | 8.81 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-007238 · edgar.xml · nonDerivative · entry 2 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,104.16 F1 · price: Each Initial Restricted Stock Unit (RSU) represents the right to receive one share of Class A common stock. F3 · price: 2017 Annual RSUs were issued as dividend equivalents on holder's underlying Annual RSUs issued on July 1, 2017. The dividend equivalent Annual RSUs will vest concurrently with the vesting of the underlying Annual RSUs. Read SEC document |
| May 17, 2018 Filed May 21, 2018 16:31 UTC | Moelis & Co MC · Entity 3898 | Grant2016 Annual Restricted Stock Units | 16.59 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-007238 · edgar.xml · nonDerivative · entry 1 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,079.24 F1 · price: Each Initial Restricted Stock Unit (RSU) represents the right to receive one share of Class A common stock. F2 · price: 2016 Annual RSUs were issued as dividend equivalents on holder's underlying Annual RSUs issued on July 1, 2016. The dividend equivalent Annual RSUs will vest concurrently with the vesting of the underlying Annual RSUs. Read SEC document |
| April 16, 2018 Filed Aug 14, 2018 22:21 UTC | ALNYLAM PHARMACEUTICALS, INC. ALNY · Entity 3132 | OtherCommon Stock | 37 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-18-000051 · edgardoc.xml · nonDerivative · entry 3 Greenstreet Yvonne · CIK 0001446125 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Managed Account Disclosed balance after: 270 F2 · kind: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. F2 · price: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. F2 · ownership.nature: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. Read SEC document |
| March 26, 2018 Filed Mar 28, 2018 20:39 UTC | ALNYLAM PHARMACEUTICALS, INC. ALNY · Entity 3132 | Exercise / conversionStock Option (right to buy) · Derivative | 7,221 | $0.00 Strike: $42.22 | $0.00 |
DisclosureSEC source: 0001553878-18-000032 · edgardoc.xml · derivative · entry 7 Greenstreet Yvonne · CIK 0001446125 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,779 Underlying: Common Stock · 7,221 shares Expires 2026-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 17, 2018. F6 · derivative.exercise_date: The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| March 26, 2018 Filed Mar 28, 2018 20:39 UTC | ALNYLAM PHARMACEUTICALS, INC. ALNY · Entity 3132 | OtherCommon Stock | 233 | $0.00 | $0.00 |
DisclosureSEC source: 0001553878-18-000032 · edgardoc.xml · nonDerivative · entry 6 Greenstreet Yvonne · CIK 0001446125 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Managed Account Disclosed balance after: 233 F5 · kind: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. F5 · price: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. F5 · ownership.nature: Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. Read SEC document |
| March 26, 2018 Filed Mar 28, 2018 20:39 UTC | ALNYLAM PHARMACEUTICALS, INC. ALNY · Entity 3132 | SaleCommon Stock | 100 | $141.47 | $14,147.00 |
DisclosureSEC source: 0001553878-18-000032 · edgardoc.xml · nonDerivative · entry 5 Greenstreet Yvonne · CIK 0001446125 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 17, 2018. Read SEC document |
| March 26, 2018 Filed Mar 28, 2018 20:39 UTC | ALNYLAM PHARMACEUTICALS, INC. ALNY · Entity 3132 | SaleCommon Stock | 419 | $137.78 | $57,729.82 |
DisclosureSEC source: 0001553878-18-000032 · edgardoc.xml · nonDerivative · entry 4 Greenstreet Yvonne · CIK 0001446125 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 17, 2018. F4 · price: Sales prices ranged from $137.68 to $137.99. Read SEC document |
| March 26, 2018 Filed Mar 28, 2018 20:39 UTC | ALNYLAM PHARMACEUTICALS, INC. ALNY · Entity 3132 | SaleCommon Stock | 2,394 | $137.09 | $328,193.46 |
DisclosureSEC source: 0001553878-18-000032 · edgardoc.xml · nonDerivative · entry 3 Greenstreet Yvonne · CIK 0001446125 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 519 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 17, 2018. F3 · price: Sales prices ranged from $136.61 to $137.58. Read SEC document |
| March 26, 2018 Filed Mar 28, 2018 20:39 UTC | ALNYLAM PHARMACEUTICALS, INC. ALNY · Entity 3132 | SaleCommon Stock | 4,308 | $136.00 | $585,888.00 |
DisclosureSEC source: 0001553878-18-000032 · edgardoc.xml · nonDerivative · entry 2 Greenstreet Yvonne · CIK 0001446125 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,913 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 17, 2018. F2 · price: Sales prices ranged from $135.53 to $136.51. Read SEC document |
| March 26, 2018 Filed Mar 28, 2018 20:39 UTC | ALNYLAM PHARMACEUTICALS, INC. ALNY · Entity 3132 | Exercise / conversionCommon Stock | 7,221 | $42.22 | $304,870.62 |
DisclosureSEC source: 0001553878-18-000032 · edgardoc.xml · nonDerivative · entry 1 Greenstreet Yvonne · CIK 0001446125 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,221 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 17, 2018. Read SEC document |
| March 07, 2018 Filed Mar 9, 2018 16:04 UTC | Moelis & Co MC · Entity 3898 | Grant2017 Elective Restricted Stock Units | 19.99 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-003951 · edgar.xml · nonDerivative · entry 3 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 548.21 F1 · price: Each Initial Restricted Stock Unit (RSU) represents the right to receive one share of Class A common stock. F4 · price: 2017 Elective RSUs were issued as dividend equivalents on holder's underlying Elective RSUs issued on July 1, 2017. The dividend equivalent Elective RSUs will vest concurrently with the vesting of the underlying Elective RSUs. Read SEC document |
| March 07, 2018 Filed Mar 9, 2018 16:04 UTC | Moelis & Co MC · Entity 3898 | Grant2017 Annual Restricted Stock Units | 39.95 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-003951 · edgar.xml · nonDerivative · entry 2 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,095.35 F1 · price: Each Initial Restricted Stock Unit (RSU) represents the right to receive one share of Class A common stock. F3 · price: 2017 Annual RSUs were issued as dividend equivalents on holder's underlying Annual RSUs issued on July 1, 2017. The dividend equivalent Annual RSUs will vest concurrently with the vesting of the underlying Annual RSUs. Read SEC document |
| March 07, 2018 Filed Mar 9, 2018 16:04 UTC | Moelis & Co MC · Entity 3898 | Grant2016 Annual Restricted Stock Units | 75.22 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-003951 · edgar.xml · nonDerivative · entry 1 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,062.65 F1 · price: Each Initial Restricted Stock Unit (RSU) represents the right to receive one share of Class A common stock. F2 · price: 2016 Annual RSUs were issued as dividend equivalents on holder's underlying Annual RSUs issued on July 1, 2016. The dividend equivalent Annual RSUs will vest concurrently with the vesting of the underlying Annual RSUs. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 22:48 UTC | ALNYLAM PHARMACEUTICALS, INC. ALNY · Entity 3132 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $119.13 | $0.00 |
DisclosureSEC source: 0001553878-18-000010 · edgardoc.xml · derivative · entry 1 Greenstreet Yvonne · CIK 0001446125 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2028-02-28 F1 · shares: Represents the time-vested portion of the reporting person's Annual Stock Option Award for 2017. The reporting person also received 25,000 options to purchase shares of ALNY common stock that will vest upon the achievement of three specific performance conditions, which will be reported on a Form 4 if and when each performance condition is met and the option vests. F2 · derivative.exercise_date: The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to the remaining shares ratably at the end of each three-month period thereafter over the following thirty-three (33) months Read SEC document |
| December 20, 2017 Filed Dec 21, 2017 22:00 UTC | ALNYLAM PHARMACEUTICALS, INC. ALNY · Entity 3132 | GrantPerformance Stock Option 2016 (right to buy) · Derivative | 6,250 | $0.00 Strike: $42.22 | $0.00 |
DisclosureSEC source: 0001325812-17-000039 · edgardoc.xml · derivative · entry 1 Greenstreet Yvonne · CIK 0001446125 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 6,250 shares Expires 2026-12-20 F1 · kind: On December 20, 2016, the reporting person was granted a performance based stock option to purchase shares of ALNY common stock. One quarter of the shares subject to the option will vest upon the achievement of each of four specific clinical development, regulatory or commercial events, as approved by our compensation committee. Effective December 20, 2017, the compensation committee of the Company determined the first performance criterion had been met and the option vested as to one-quarter of the shares. Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 16:29 UTC | Moelis & Co MC · Entity 3898 | Grant2017 Elective Restricted Stock Units | 6.32 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-014541 · edgar.xml · nonDerivative · entry 3 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 791.81 F1 · price: Each Initial Restricted Stock Unit (RSU) represents the right to receive one share of Class A common stock. F4 · price: 2017 Elective RSUs were issued as dividend equivalents on holder's underlying Elective RSUs issued on July 1, 2017. The dividend equivalent Elective RSUs will vest concurrently with the vesting of the underlying Elective RSUs. Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 16:29 UTC | Moelis & Co MC · Entity 3898 | Grant2017 Annual Restricted Stock Units | 8.43 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-014541 · edgar.xml · nonDerivative · entry 2 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,055.41 F1 · price: Each Initial Restricted Stock Unit (RSU) represents the right to receive one share of Class A common stock. F3 · price: 2017 Annual RSUs were issued as dividend equivalents on holder's underlying Annual RSUs issued on July 1, 2017. The dividend equivalent Annual RSUs will vest concurrently with the vesting of the underlying Annual RSUs. Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 16:29 UTC | Moelis & Co MC · Entity 3898 | Grant2016 Annual Restricted Stock Units | 15.88 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-014541 · edgar.xml · nonDerivative · entry 1 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,987.43 F1 · price: Each Initial Restricted Stock Unit (RSU) represents the right to receive one share of Class A common stock. F2 · price: 2016 Annual RSUs were issued as dividend equivalents on holder's underlying Annual RSUs issued on July 1, 2016. The dividend equivalent Annual RSUs will vest concurrently with the vesting of the underlying Annual RSUs. Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 18:18 UTC | Moelis & Co MC · Entity 3898 | Grant2017 Elective Restricted Stock Units | 9.98 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-011714 · edgar.xml · nonDerivative · entry 3 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,046.98 F1 · price: Each Initial Restricted Stock Unit (RSU) represents the right to receive one share of Class A common stock. F4 · price: 2017 Elective RSUs were issued as dividend equivalents on holder's underlying Elective RSUs issued on July 1, 2017. The dividend equivalent Elective RSUs will vest concurrently with the vesting of the underlying Elective RSUs. Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 18:18 UTC | Moelis & Co MC · Entity 3898 | Grant2017 Annual Restricted Stock Units | 9.98 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-011714 · edgar.xml · nonDerivative · entry 2 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,046.98 F1 · price: Each Initial Restricted Stock Unit (RSU) represents the right to receive one share of Class A common stock. F3 · price: 2017 Annual RSUs were issued as dividend equivalents on holder's underlying Annual RSUs issued on July 1, 2017. The dividend equivalent Annual RSUs will vest concurrently with the vesting of the underlying Annual RSUs. Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 18:18 UTC | Moelis & Co MC · Entity 3898 | Grant2016 Annual Restricted Stock Units | 18.79 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-011714 · edgar.xml · nonDerivative · entry 1 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,971.55 F1 · price: Each Initial Restricted Stock Unit (RSU) represents the right to receive one share of Class A common stock. F2 · price: 2016 Annual RSUs were issued as dividend equivalents on holder's underlying Annual RSUs issued on July 1, 2016. The dividend equivalent Annual RSUs will vest concurrently with the vesting of the underlying Annual RSUs. Read SEC document |
| July 06, 2017 Filed Jul 10, 2017 16:37 UTC | Moelis & Co MC · Entity 3898 | Grant2016 Annual Restricted Stock Units | 48.64 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-010257 · edgar.xml · nonDerivative · entry 2 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,952.76 F1 · price: Each Initial Restricted Stock Unit (RSU) represents the right to receive one share of Class A common stock. F3 · price: 2016 Annual RSUs were issued as dividend equivalents on holder's underlying Annual RSUs issued on July 1, 2016. The dividend equivalent Annual RSUs will vest concurrently with the vesting of the underlying Annual RSUs. Read SEC document |
| July 06, 2017 Filed Jul 10, 2017 16:37 UTC | Moelis & Co MC · Entity 3898 | Grant2015 Stub Annual Restricted Stock Units | 14.88 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-010257 · edgar.xml · nonDerivative · entry 1 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 597.37 F1 · price: Each Initial Restricted Stock Unit (RSU) represents the right to receive one share of Class A common stock. F2 · price: Stub Annual RSUs were issued as dividend equivalents on holder's underlying Stub Annual RSUs issued on July 10, 2015 (and dividend equivalents thereon). The dividend equivalent Stub Annual RSUs will vest concurrently with the vesting of the underlying Stub Annual RSUs. Read SEC document |
| July 01, 2017 Filed Jul 5, 2017 16:15 UTC | Moelis & Co MC · Entity 3898 | Grant2017 Elective Restricted Stock Units | 1,037 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-009980 · edgar.xml · nonDerivative · entry 2 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,037 F1 · security: Each Restricted Stock Unit represents the right to receive one share of Class A common stock upon settlement. Grant of Restricted Stock Units pursuant to the Moelis & Company 2014 Omnibus Plan. F4 · date: The 2017 Elective Restricted Stock Units vest in equal fourths at the beginning of each quarter, ending on July 1, 2018 and settlement is within 60 days following the applicable vesting date. F1 · price: Each Restricted Stock Unit represents the right to receive one share of Class A common stock upon settlement. Grant of Restricted Stock Units pursuant to the Moelis & Company 2014 Omnibus Plan. F2 · price: Restricted Stock Units granted to Non-employee Director based on $38.56 per share of Class A Common Stock, which was the average closing price of the Company's Class A common stock on the NYSE for the five trading days ended on June 30, 2017. Read SEC document |
| July 01, 2017 Filed Jul 5, 2017 16:15 UTC | Moelis & Co MC · Entity 3898 | Grant2017 Annual Restricted Stock Units | 1,037 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-009980 · edgar.xml · nonDerivative · entry 1 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,037 F1 · security: Each Restricted Stock Unit represents the right to receive one share of Class A common stock upon settlement. Grant of Restricted Stock Units pursuant to the Moelis & Company 2014 Omnibus Plan. F3 · date: The 2017 Annual Restricted Stock Units vested on July 1, 2017 and settlement is within 60 days following July 1, 2019. F1 · price: Each Restricted Stock Unit represents the right to receive one share of Class A common stock upon settlement. Grant of Restricted Stock Units pursuant to the Moelis & Company 2014 Omnibus Plan. F2 · price: Restricted Stock Units granted to Non-employee Director based on $38.56 per share of Class A Common Stock, which was the average closing price of the Company's Class A common stock on the NYSE for the five trading days ended on June 30, 2017. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:13 UTC | Pacira BioSciences, Inc. PCRX · Entity 4928 | GrantStock Option (Right to Buy) · Derivative | 2,714 | $0.00 Strike: $44.20 | $0.00 |
DisclosureSEC source: 0001209191-17-040689 · doc4.xml · derivative · entry 2 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,714 Underlying: Common Stock · 2,714 shares Expires 2027-06-14 F2 · derivative.exercise_date: The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:13 UTC | Pacira BioSciences, Inc. PCRX · Entity 4928 | GrantCommon Stock | 1,357 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040689 · doc4.xml · nonDerivative · entry 1 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,845 F1 · shares: Represents restricted stock units that vest on June 3, 2018, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| May 24, 2017 Filed May 26, 2017 16:26 UTC | Moelis & Co MC · Entity 3898 | Grant2016 Annual Restricted Stock Units | 19.27 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-008087 · edgar.xml · nonDerivative · entry 2 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,904.13 F1 · price: Each Initial Restricted Stock Unit (RSU) represents the right to receive one share of Class A common stock. F3 · price: 2016 Annual RSUs were issued as dividend equivalents on holder's underlying Annual RSUs issued on July 1, 2016. The dividend equivalent Annual RSUs will vest concurrently with the vesting of the underlying Annual RSUs. Read SEC document |
| May 24, 2017 Filed May 26, 2017 16:26 UTC | Moelis & Co MC · Entity 3898 | Grant2015 Stub Annual Restricted Stock Units | 5.89 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-008087 · edgar.xml · nonDerivative · entry 1 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 582.49 F1 · price: Each Initial Restricted Stock Unit (RSU) represents the right to receive one share of Class A common stock. F2 · price: Stub Annual RSUs were issued as dividend equivalents on holder's underlying Stub Annual RSUs issued on July 10, 2015 (and dividend equivalents thereon). The dividend equivalent Stub Annual RSUs will vest concurrently with the vesting of the underlying Stub Annual RSUs. Read SEC document |
| March 17, 2017 Filed Mar 21, 2017 16:18 UTC | Moelis & Co MC · Entity 3898 | Grant2016 Annual Restricted Stock Units | 18.17 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-004976 · edgar.xml · nonDerivative · entry 2 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,884.86 F1 · price: Each Initial Restricted Stock Unit (RSU) represents the right to receive one share of Class A common stock. F3 · price: 2016 Annual RSUs were issued as dividend equivalents on holder's underlying Annual RSUs issued on July 1, 2016. The dividend equivalent Annual RSUs will vest concurrently with the vesting of the underlying Annual RSUs. Read SEC document |
| March 17, 2017 Filed Mar 21, 2017 16:18 UTC | Moelis & Co MC · Entity 3898 | Grant2015 Stub Annual Restricted Stock Units | 5.56 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-004976 · edgar.xml · nonDerivative · entry 1 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 576.59 F1 · price: Each Initial Restricted Stock Unit (RSU) represents the right to receive one share of Class A common stock. F2 · price: Stub Annual RSUs were issued as dividend equivalents on holder's underlying Stub Annual RSUs issued on July 10, 2015 (and dividend equivalents thereon). The dividend equivalent Stub Annual RSUs will vest concurrently with the vesting of the underlying Stub Annual RSUs. Read SEC document |
| January 05, 2017 Filed Jan 9, 2017 17:28 UTC | Moelis & Co MC · Entity 3898 | Grant2016 Annual Restricted Stock Units | 66.95 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-000801 · edgar.xml · nonDerivative · entry 3 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,866.68 F1 · price: Each Initial Restricted Stock Unit (RSU) represents the right to receive one share of Class A common stock. F4 · price: 2016 Annual RSUs were issued as dividend equivalents on holder's underlying Annual RSUs issued on July 1, 2016. The dividend equivalent Annual RSUs will vest concurrently with the vesting of the underlying Annual RSUs. Read SEC document |
| January 05, 2017 Filed Jan 9, 2017 17:28 UTC | Moelis & Co MC · Entity 3898 | Grant2015 Stub Annual Restricted Stock Units | 20.48 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-000801 · edgar.xml · nonDerivative · entry 2 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 571.03 F1 · price: Each Initial Restricted Stock Unit (RSU) represents the right to receive one share of Class A common stock. F3 · price: Stub Annual RSUs were issued as dividend equivalents on holder's underlying Stub Annual RSUs issued on July 10, 2015 (and dividend equivalents thereon). The dividend equivalent Stub Annual RSUs will vest concurrently with the vesting of the underlying Stub Annual RSUs. Read SEC document |
| January 05, 2017 Filed Jan 9, 2017 17:28 UTC | Moelis & Co MC · Entity 3898 | GrantInitial Restricted Stock Units | 54.37 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-000801 · edgar.xml · nonDerivative · entry 1 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,515.88 F1 · price: Each Initial Restricted Stock Unit (RSU) represents the right to receive one share of Class A common stock. F2 · price: Initial RSUs were issued as dividend equivalents on holder's underlying Initial RSUs issued on February 19, 2015 (and dividend equivalents thereon). The dividend equivalent Initial RSUs will vest concurrently with the vesting of underlying Initial RSUs. Read SEC document |
| December 20, 2016 Filed Dec 22, 2016 21:19 UTC | ALNYLAM PHARMACEUTICALS, INC. ALNY · Entity 3132 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $42.22 | $0.00 |
DisclosureSEC source: 0001325812-16-000108 · edgardoc.xml · derivative · entry 1 Greenstreet Yvonne · CIK 0001446125 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2026-12-20 F1 · shares: Represents the time-vested portion of the reporting person's 2016 Annual Stock Option award. The reporting person also received an option to purchase 25,000 shares of ALNY common stock that will vest upon the achievement of four specific performance conditions, which will be reported on a Form 4 if and when each performance condition is met and the option vests. F2 · derivative.exercise_date: The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| December 07, 2016 Filed Dec 9, 2016 16:14 UTC | Moelis & Co MC · Entity 3898 | Grant2016 Annual Restricted Stock Units | 19.05 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-16-032691 · edgar.xml · nonDerivative · entry 3 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,799.73 F1 · price: Each Initial Restricted Stock Unit (RSU) represents the right to receive one share of Class A common stock. F4 · price: 2016 Annual RSUs were issued as dividend equivalents on holder's underlying Annual RSUs issued on July 1, 2016. The dividend equivalent Annual RSUs will vest concurrently with the vesting of the underlying Annual RSUs. Read SEC document |
| December 07, 2016 Filed Dec 9, 2016 16:14 UTC | Moelis & Co MC · Entity 3898 | Grant2015 Stub Annual Restricted Stock Units | 5.82 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-16-032691 · edgar.xml · nonDerivative · entry 2 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550.55 F1 · price: Each Initial Restricted Stock Unit (RSU) represents the right to receive one share of Class A common stock. F3 · price: Stub Annual RSUs were issued as dividend equivalents on holder's underlying Stub Annual RSUs issued on July 10, 2015 (and dividend equivalents thereon). The dividend equivalent Stub Annual RSUs will vest concurrently with the vesting of the underlying Stub Annual RSUs. Read SEC document |
| December 07, 2016 Filed Dec 9, 2016 16:14 UTC | Moelis & Co MC · Entity 3898 | GrantInitial Restricted Stock Units | 15.47 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-16-032691 · edgar.xml · nonDerivative · entry 1 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,461.5 F1 · price: Each Initial Restricted Stock Unit (RSU) represents the right to receive one share of Class A common stock. F2 · price: Initial RSUs were issued as dividend equivalents on holder's underlying Initial RSUs issued on February 19, 2015 (and dividend equivalents thereon). The dividend equivalent Initial RSUs will vest concurrently with the vesting of underlying Initial RSUs. Read SEC document |
| September 19, 2016 Filed Sep 21, 2016 22:33 UTC | ALNYLAM PHARMACEUTICALS, INC. ALNY · Entity 3132 | GrantStock Option (right to buy) · Derivative | 125,000 | $0.00 Strike: $77.10 | $0.00 |
DisclosureSEC source: 0001553878-16-000056 · edgardoc.xml · derivative · entry 1 Greenstreet Yvonne · CIK 0001446125 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2026-09-18 F1 · derivative.exercise_date: The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| September 06, 2016 Filed Sep 8, 2016 16:28 UTC | Moelis & Co MC · Entity 3898 | Grant2016 Annual Restricted Stock Units | 21.67 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-16-029437 · edgar.xml · nonDerivative · entry 3 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,780.67 F1 · price: Each Initial Restricted Stock Unit (RSU) represents the right to receive one share of Class A common stock. F4 · price: 2016 Annual RSUs were issued as dividend equivalents on holder's underlying Annual RSUs issued on July 1, 2016. The dividend equivalent Annual RSUs will vest concurrently with the vesting of the underlying Annual RSUs. Read SEC document |
| September 06, 2016 Filed Sep 8, 2016 16:28 UTC | Moelis & Co MC · Entity 3898 | Grant2015 Stub Annual Restricted Stock Units | 6.63 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-16-029437 · edgar.xml · nonDerivative · entry 2 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 544.72 F1 · price: Each Initial Restricted Stock Unit (RSU) represents the right to receive one share of Class A common stock. F3 · price: Stub Annual RSUs were issued as dividend equivalents on holder's underlying Stub Annual RSUs issued on July 10, 2015 (and dividend equivalents thereon). The dividend equivalent Stub Annual RSUs will vest concurrently with the vesting of the underlying Stub Annual RSUs. Read SEC document |
| September 06, 2016 Filed Sep 8, 2016 16:28 UTC | Moelis & Co MC · Entity 3898 | GrantInitial Restricted Stock Units | 17.6 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-16-029437 · edgar.xml · nonDerivative · entry 1 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,446.03 F1 · price: Each Initial Restricted Stock Unit (RSU) represents the right to receive one share of Class A common stock. F2 · price: Initial RSUs were issued as dividend equivalents on holder's underlying Initial RSUs issued on February 19, 2015 (and dividend equivalents thereon). The dividend equivalent Initial RSUs will vest concurrently with the vesting of underlying Initial RSUs. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.